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ABSTRACT 
FDG-PET/CT is a widely established imaging modality for staging, restaging and monitoring therapy response in 
lymphoma patients. Progressive transformation of germinal centres (PTGC) is a benign condition presenting 
characteristically as asymptomatic lymphadenopathy. This paper presents a case of a 53-year-old man with a history of 
Hodgkin’s disease (HD) whose F
18
 FDG-PET/CT scan showed high uptake in left axillary lymph nodes (SUV 3.8). A 
subsequent, left axillary lymph node biopsy revealed PTGC. PTGC can present as a false positive finding on FDG-
PET/CT in lymphoma patients and biopsy should be done in HD patients in clinical remission but have a positive FDG-
PET/CT scan. © 2008 Biomedical Imaging and Intervention Journal. All rights reserved. 
Keywords: F18 FDG-PET/CT, Progressive Transformation of Germinal Centres (PTGC), Hodgkin’s disease (HD) 
 
CASE REPORT 
A 53-year-old man underwent FDG-PET/CT 
scanning for detection of recurrent disease. He was 
diagnosed with Hodgkin’s disease (HD) five years ago 
and successfully treated with chemotherapy. The patient 
was asymptomatic. 12.6 mCi FDG was injected and 
images acquired using a Siemens Biograph 6 PET-CT 
scanner (Siemens AG, Munich) (Figure 1). The PET/CT 
image showed small lymph nodes in the left axilla with 
the highest standardised uptake value of 3.8 and 
measuring less than 1 cm in size. FDG-PET/CT imaging 
has been found to have higher accuracy than FDG-PET 
and CT alone in staging and restaging of patients with 
lymphoma [1,2].  
Left axillary lymph node biopsy was performed and 
revealed progressive transformation of germinal centres 
(PTGC). Figure 2a shows progressive transformed 
germinal centre and loss of normal architecture, while 
Figure 2b shows small lymphocytes, histiocytes and 
immunoblasts. 
DISCUSSION 
PTGC was initially described by Lennert and 
Muller-Hermerlink as large follicles composed 
predominantly of diffuse small lymphocytes and an 
obscured mantle zone [3]. PTGC is most commonly seen 
in lymph nodes in association with reactive follicular 
hyperplasia [4]. PTGC may precede lymphocyte 
predominant Hodgkin’s disease (LPHD) or can be 
present subsequently in lymph node biopsies of 
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(a) 
 
(b) 
Figure 1 FDG PET-CT scan of the patient. Arrow shows small lymph nodes in the left axilla with the highest 
standardised uptake value of 3.8 and measuring less than 1 cm in size. 
 
 
 
 
 
 
(a) 
 
(b) 
Figure 2 Photomicrograph of left axillary lymph node biopsy (a) shows progressive transformed germinal centre 
and loss of normal architecture (haematoxylin and eosin stain, x10); (b) shows small lymphocytes, 
histiocytes and immunoblasts (haematoxylin and eosin stain, x40). 
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as seen in this case; but the presence 
of PTGC is not associated definitively with an increased 
risk of developing HD [5]. 
The causes of false positive FDG-PET/CT include 
infection, inflammation, granulomatous disease [6,7] and 
immunisation [8]. However, the FDG uptake in PTGC 
has been rarely documented in literature [9]
 
and can 
present as a false positive finding on FDG-PET/CT scan. 
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